http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110157658-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_318d3ae9e6b87c6a6b9bedb644827ad0 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-999 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-115 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0621 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-079 |
filingDate | 2019-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3884c220f1587e13575a34d13a46e734 |
publicationDate | 2019-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-110157658-A |
titleOfInvention | A kind of stem cell external evoked method for cultivating retinal ganglial cells |
abstract | The present invention relates to stem cell fields, a kind of stem cell external evoked method for cultivating retinal ganglial cells are provided, for solving the problems, such as the reparation of retina neural.The stem cell external evoked method for cultivating retinal ganglial cells of one kind provided by the invention, comprising: S11. is derived from somatic stem cell and single cell suspension is made;S12. 10 are diluted to differential medium after single cell suspension being counted ‑5 ~10 ‑3 The stem cell suspension of cells/mL, is inoculated into culture dish, obtains embryoid body;S13. it is transferred in inductive differentiation medium after embryoid body being proliferated, in 37 DEG C, 5%CO 2 , carry out under saturated humidity intervening differentiation culture.The retinal ganglial cells that autologous stem cells are differentiated to form can be used for the number and function of recovery retinal ganglial cells after optic nerve damage, not only facilitate the deterioration for slowing down optic nerve injury patient's state of an illness, the recovery for promoting patient visual's function will also promote the reconstruction for damaging optic structure and function. |
priorityDate | 2019-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 65.